Biohaven Ltd. (BHVN)
NYSE: BHVN · Real-Time Price · USD
9.55
-0.06 (-0.62%)
Dec 5, 2025, 4:00 PM EST - Market closed
Biohaven Market Cap
Biohaven has a market cap or net worth of $1.27 billion as of December 5, 2025. Its market cap has decreased by -72.93% in one year.
Market Cap
1.27B
Enterprise Value
1.32B
1-Year Change
-72.93%
Ranking
Category
Stock Price
$9.55
Market Cap Chart
Since September 23, 2022, Biohaven's market cap has increased from $261.58M to $1.27B, an increase of 384.44%. That is a compound annual growth rate of 63.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 1.27B | -66.45% |
| Dec 31, 2024 | 3.78B | 9.99% |
| Dec 29, 2023 | 3.43B | 262.97% |
| Dec 30, 2022 | 946.07M | 261.68% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |